A carregar...
Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non‐Small Cell Lung Carcinoma
Concomitant administration of bevacizumab and pemetrexed‐cisplatin is a common treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC). Vascular normalization following bevacizumab administration may transiently enhance drug delivery, suggesting improved efficacy with sequential admini...
Na minha lista:
Publicado no: | CPT Pharmacometrics Syst Pharmacol |
---|---|
Main Authors: | , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5784740/ https://ncbi.nlm.nih.gov/pubmed/29218795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12265 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|